Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
Clinical trial NCT03386513 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03386513
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-02
- Primary completion
- 2023-09-06
- Enrollment
- 179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.